Determination of prednisolone metabolites in beef cattle

Abstract

Prednisolone is a synthetic corticosteroid acting on both hydrosaline balance and metabolism that is liable to fraudulent administration to meat-producing animals for growth-promoting purposes. Its use outside strict therapeutic control and prescription is banned by the European legislation, but official controls are hampered by its negligible direct excretion into the urinary matrix. Recent studies reported on a potential endogenous origin of prednisolone in animals subjected to stressful conditions, accounting for its occasional detection in control urines. The objective of the present study was the identification and quantification of prednisolone urinary metabolites to be used as illicit treatment biomarkers in place of the parent drug. An LC-MS/MS screening was conducted on urine samples collected from a bullock intramuscularly administered with prednisolone acetate by using a therapeutic protocol (2 × 0.52 mg kg⁻¹ at 48-hour interval). Four prednisolone metabolites were identified: 20β-dihydroprednisolone, 20α-dihydroprednisolone, 6β-hydroxyprednisolone and 20β-dihydroprednisone; the first was detected at relatively high concentrations. An existing quantitative LC-MS/MS method was expanded and revalidated to include these metabolites. The new analytical method proved sensitive (LODs: 0.35–0.42 ng mL⁻¹) and specific and was applied to urine samples collected from eight beef cattle subjected to low-dosage oral administration of prednisolone acetate for a 35-day period, as in standard growth-promoting treatments. 20β-Dihydroprednisolone was detected in all urine samples collected during the treatment, at relatively high concentration (1.2−27 ng mL⁻¹), whereas the prednisolone concentration was virtually negligible (<0.7 ng mL⁻¹). 20β-Dihydroprednisolone was no longer present in almost all samples collected 6 days after the end of the treatment, but trace amounts of this metabolite were found in two urine samples from control animals. 20β-Dihydroprednisolone is proposed as an effective biomarker to test illegal growth-promoting treatments with prednisolone in meat cattle, alternatively to the parent drug.

Keywords:

• prednisolone
• metabolites
• urine
• beef cattle
• LC-MS/MS

Acknowledgements

Continuous support from Regione Piemonte is gratefully acknowledged by all authors and participating institutions. In particular, this work was funded by the project “Prevenzione dell’uso di anabolizzanti in zootecnia: le biotecnologie nello sviluppo di disciplinary per la qualità e la salubrità della carne e derivati” by the Ministero delle Politiche Agricole Alimentari e Forestali – project SAFORISK and by the italian Ministry of Education, University and Research (MIUR).